Literature DB >> 9794815

The nuclear receptor PPARgamma - bigger than fat.

S A Kliewer1, T M Willson.   

Abstract

Work reported over the past year has provided insights into the mechanisms whereby ligand activation of the nuclear receptor peroxisome proliferator-activated receptor gamma (PPARgamma) regulates systemic glucose and lipid homeostasis. PPARgamma has also been implicated recently in the biology of monocytes and in cell-cycle regulation and cancer. Polyunsaturated fatty acids and eicosanoids bind and activate PPARgamma, suggesting that these lipids may serve as hormonal regulators of a variety of biological processes.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9794815     DOI: 10.1016/s0959-437x(98)80014-2

Source DB:  PubMed          Journal:  Curr Opin Genet Dev        ISSN: 0959-437X            Impact factor:   5.578


  21 in total

1.  Identification of a peroxisome-proliferator-activated-receptor response element in the apolipoprotein E gene control region.

Authors:  R Galetto; M Albajar; J I Polanco; M M Zakin; J C Rodríguez-Rey
Journal:  Biochem J       Date:  2001-07-15       Impact factor: 3.857

2.  Combined effects of the C161T and Pro12Ala PPARγ2 gene variants with insulin resistance on metabolic syndrome: a case-control study of a central Tunisian population.

Authors:  Sarraj Mohamed Youssef; Najah Mohamed; Slimani Afef; Ben Hamda Khaldoun; Neffati Fadoua; Najjar Mohamed Fadhel; Slimene Mohamed Naceur
Journal:  J Mol Neurosci       Date:  2013-11-19       Impact factor: 3.444

3.  Inhibition of cancer cell proliferation by PPARγ is mediated by a metabolic switch that increases reactive oxygen species levels.

Authors:  Nishi Srivastava; Rahul K Kollipara; Dinesh K Singh; Jessica Sudderth; Zeping Hu; Hien Nguyen; Shan Wang; Caroline G Humphries; Ryan Carstens; Kenneth E Huffman; Ralph J DeBerardinis; Ralf Kittler
Journal:  Cell Metab       Date:  2014-09-25       Impact factor: 27.287

4.  Prostaglandin D(2), its metabolite 15-d-PGJ(2), and peroxisome proliferator activated receptor-gamma agonists induce apoptosis in transformed, but not normal, human T lineage cells.

Authors:  Sarah G Harris; Richard P Phipps
Journal:  Immunology       Date:  2002-01       Impact factor: 7.397

5.  Effect of the PPARγ C161T gene variant on serum lipids in ischemic stroke patients with and without type 2 diabetes mellitus.

Authors:  Khouloud Chehaibi; Samir Nouira; Kacem Mahdouani; Sonia Hamdi; Mustapha Rouis; Mohamed Naceur Slimane
Journal:  J Mol Neurosci       Date:  2014-05-21       Impact factor: 3.444

6.  Influence of peroxisome proliferator-activated receptor (PPAR)gamma Plo12Ala polymorphism as a shared risk marker for both gastric cancer and impaired fasting glucose (IFG) in Japanese.

Authors:  Tomomitsu Tahara; Tomiyasu Arisawa; Tomoyuki Shibata; Masakatsu Nakamura; Fangyu Wang; Naoko Maruyama; Yoshio Kamiya; Masahiko Nakamura; Hiroshi Fujita; Mitsuo Nagasaka; Masami Iwata; Kazuya Takahama; Makoto Watanabe; Ichiro Hirata; Hiroshi Nakano
Journal:  Dig Dis Sci       Date:  2007-09-01       Impact factor: 3.199

7.  Sequence analysis of bovine C/EBPδ gene and its adipogenic effects on fibroblasts.

Authors:  Hong Wang; Gong Cheng; Changzhen Fu; Hongbao Wang; Wucai Yang; Hongcheng Wang; Linsen Zan
Journal:  Mol Biol Rep       Date:  2013-11-09       Impact factor: 2.316

8.  Fish oil inhibits human lung carcinoma cell growth by suppressing integrin-linked kinase.

Authors:  Shouwei Han; Xiaojuan Sun; Jeffrey D Ritzenthaler; Jesse Roman
Journal:  Mol Cancer Res       Date:  2009-01       Impact factor: 5.852

9.  Association of peroxisome proliferator-activated receptorγ gene Pro12Ala and C161T polymorphisms with cardiovascular risk factors in maintenance hemodialysis patients.

Authors:  Feng Liu; Xiaobin Mei; Yingying Zhang; Hualin Qi; Jun Wang; Yi Wang; Wei Jiang; Xintian Zhang; Haidong Yan; Shougang Zhuang
Journal:  Mol Biol Rep       Date:  2014-08-06       Impact factor: 2.316

10.  PPARgamma gene C161T substitution alters lipid profile in Chinese patients with coronary artery disease and type 2 diabetes mellitus.

Authors:  Jing Wan; Shixi Xiong; Shengping Chao; Jianming Xiao; Yexin Ma; Jinghua Wang; Sabita Roy
Journal:  Cardiovasc Diabetol       Date:  2010-03-24       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.